Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Financing › Details

Cellink–SEVERAL: investment, 202103 capital increase SEK1.5b directed issue of new Class B Shares at SEK420/share

 

Period Period 2021-03-12
  Predecessor Cellink–SEVERAL: investment, 201906 capital raising SEK148.5m with institutional investors
Organisations Money taker Cellink (Group)
  Money source SEVERAL
Products Product BIOTECH
  Product 2 investment banking
Index terms Index term MatTek–Cellink: investment, 202103– acquisition $68m net of cash/debt with $54.4m in cash + $13.6m in shares ANNOUNCED
  Index term 2 Cellink–SEVERAL: credit, 202103–202603 convertible bonds SEK1.5b at 2.875%pa convertible into B Class shares at SEK598.5/share
Document Source Cellink AB. (3/12/21). "Press Release: Cellink AB (publ) Announces the Completion of the Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Overall Amount of SEK 3.0 Billion [NOT FOR US, CA, AU,
     

   
Record changed: 2021-04-12

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Cellink (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px




» top